Congressional Diabetes Caucus

Insulin Prices Begin Tripling 2002-2013 as Three Manufacturers Control 99% of Market - From $231 to $762 Annually

| Importance: 9/10

The average price of insulin in the United States began a decade-long tripling from $231 per patient annually in 2002 to $762 in 2013, according to congressional hearing data—with some patients paying up to $900 per month for insulin products that cost $4.34 per milliliter in 2002 but reached $12.92 …

Eli Lilly Novo Nordisk Sanofi Congressional Diabetes Caucus Big Pharma pharmaceutical-industry drug-pricing healthcare monopoly insulin-crisis +1 more
Read more →